Investment Q&A

Q: Down 25% plus on these two subsidiaries so considering a tax loss sale. Would BN be a suitable proxy and stay onside with CRA rules? Other ideas?

Q: I recall once seeing a link to an explainer on all of the different Brookfield offerings. Can you please repost this. Is it up to date with the new BAM / BN thing?

Ideally hoping to see a tabulated summary including:
name of holding
nature of business
yield
ideal account type to hold in for optimal tax efficiency
closest competitor names

Which offering would you recommend for green energy income investment in an unregistered CDN$ account? Any comments on when is a good time to buy given recent structural changes and interest rate changes.

Thanks,

Jim

Q: Hi team, I just sold this position for tax loss purposes ( -45%). Still like the future of this company but still debating on repurchase it later or meta. What would be your choice for 2/4 years and why? Thank you and happy holidays to all of your staff!

Q: Could the weakness in Brookfield shares be attributable to them funding $250 million of Musk's purchase of Twitter which he has stated "has been in the fast lane to bankruptcy"? New shares are being offered at $54.20 so Brookfield may have to cough up more too.

Apparently it's Brookfield Growth that stands to lose the money - is this an arm of BN or BAM?

Q: This is probably a silly question but I don't want to make a mistake.
Instead of raising 6500.00 cash for my TFSA on Jan 1st, I'm thinking about transferring stock out of my cash account instead. I've already sold my tax loss candidates. I'm not sure how this works though. If my book cost is 6500.00 and market value is 3000.00, does that mean I've contributed my full amount? And in what scenario would this be a smart idea? I could also transfer stocks with significant capital gains.

Thanks,
Andrea

Q: General comment : first of all I wish a very happy Christmas and a wonderful New year to all of the team,and keep doing your exceptional job .. I establish my own strategy , (since I believe this should be compulsory ),and you were very helpfull in order to : 1) avoid mistakes when selecting stocks 2) to comment my choices of sectors and products in a volatile market and uncertain economic context and 3) to compare similar stocks and ETF.

Q: I remember that Peter has not always spoken fondly of Robert Friedland, while one of his former associates at Sprott, Rick Rule, has stated that Friedland is "serially successful." There is no doubt that Ivanhoe's DRC assets are first-class, but a recent article in the G & M has cast doubt on Ivanhoe's corporate practices in the DRC. The share price has dropped significantly as a result. Do you believe this is a buying opportunity, if not tomorrow then when the share price stabilizes? I am a long-term copper bull.

Q: What percentage of a portfilio would you allocate to renewable enegy. I have organized possible holdings into 3 groupings: A. asset allocators, like BEP-un, CWEN; B. technology enhancers, like ARRY, SHLS, RUN, C. Electric utility deliverers: AES, FTS. I would ssk that you recommend a your preferred namres for each grouping. My questions are: 1. Is this a useful way to organize and, if so, what percentage would you allocate to each grouping? 2. Could you rank the stocks in each grouping for safety and growth with suggested [ballpark] entry buy prices? Thanks

Q: Have you read IVN rebuttal? What do you think?

Q: LAC is buying (subject to approval) Arena by offering LAC shares but no cash. I currently hold AN and am wondering what your view of the takeover is; good, bad or indifferent? Does it make more sense to wait and take the LAC shares or sell for cash now. One concern I have is the LAC will be splitting into 2 companies but other than one company holding American properties and the other holding International properties (ie. AN) I can’t find details about the proportions of the new structure. I’m a little concerned about LAC AFTER the new companies are in place. The American focused company has current environmental issues that will presumably continue. I’m not looking for personal advice here just your opinion of a general nature. Deduct as my credits as necessary, I would value your insight as always.

Q: Based on Portfolio Analytics my portfolio needs more international exposure and more industrial exposure. To that end I am looking at BASF SE the german chemical giant currently trading at a discount with a great dividend.
Should I be worried?

Q: Today ECN traded 6 x average daily volumes, is there any way we can know who is buying? Does this enhance your buy thesis on ECN?

Q: I note you recently indicated BNRE is only convertible into BN. I have only had BNRE for a few months. Hoped it would maybe pop 10-15% in 4-6 months. What are the advantages/disadvantages if converting BNRE to BN and would you recommend someone do that now or is there an advantage to wait until sometime next year (or not convert at all) ?

Q: how do I calculate the dividend yield per share when I know the yield % and number of shares? Google doesn't want to tell me!

Q: I checked out the 5i Profile page for Theratechnologies to see if there was any news regarding the large drop on December 1st but didn't see anything. I checked out Theratechnologies Investor Relations website and found the press release regarding the enrollment pause on the Phase 1 clinicial trial of TH1902. Why doesn't this press release show up in the News & Media section on TH's Profile in 5i?

Q: Looking to do an “in kind” transfer to my TFSA in Jan - which one would you choose and why?
Much appreciated. ram

Q: Hi Peter, Ryan, and 5i Team,

Sorry for yet another Brookfield question! In my RRIF, I hold these three Brookfield entities: BEP.UN, BN, and BAM.

As a retired investor who likes dividends, and is underweight in utilities (due to recently selling AQN) and is overweight in financials, would you endorse selling BN and BAM, and using the proceeds to buy more BEP.UN? Or is there a flaw in my thinking?

Thanks as always for your timely advice, and happy holidays to everyone at 5i.

Q: Selling BN:US for Tax Loss. Please suggest a proxy - I plan to buy it back after 30 business days.

Q: In several of your responses you have stated that "BN will be more growth oriented, BAM more income-oriented. " You also state "We like BAM at the current price, with an attractive and secure dividend." However, TD Webbroker shows BAM with no dividend whereas BN shows a yield of 1.77%. Am I missing something here? Thank you.
Dennis

Q: I am a “dividend + revenue” investor, considering the high volatility, recession risks, and inflation, these are my main "moves" in 2022 :

1) Sell most of smaller Cies stocks
2) Keep selected larger Cies stocks considered to be in a good financial and strategic position
3) Keep various REITS like data centers,real estate,etc.. (no shopping centers,since on line shopping is increasing)
4) “Accept to sell” (with high profit though) some excellent large Cies stocks in order to Increase the proportion of selected ETFs (dividend and/or dividend growth), including US ETF in RRSP
5) Keep a significant proportion of utilities ETF, and Canadian financial ETFs
6) No fixed income, no bonds,and no fixed income ETF ( I wish to equal or beat inflation if possible, plus the fact that fixed income products are not easy to trade and to manage ,except for experts)
7) Increase the proportion of covered call ETFs in order to better resist to volatility and to maintain stability of revenues
8) Keep closed-end funds and split-share corporations (in a small proportion)

What are the weak points, any adjustment suggested?

Thanks, you are always very helpfull to “refine “ researchs according to various strategies